Focus Area 1 - The Silent Crisis in Joint Health

Osteoarthritis is the leading cause of chronic pain in dogs, affecting 20% of all adults and 80% of seniors. With mobility loss driving nearly 50% of owner-elected euthanasia, the "slow down" we see is actually a urgent medical emergency.

Our Solution: We are developing a precision protein therapeutic designed to go beyond surface-level pain relief. By targeting the biological drivers of inflammation at the molecular level, we aim to halt joint degradation and restore the quality of life.